ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Direct Meds Highlights Added Value and Convenience Amid Costco’s $499 GLP-1 Offer

As Costco enters the weight loss prescription market, Direct Meds highlights its all-in-one model, including prescriptions, provider care, and home delivery.

(PRUnderground) October 29th, 2025

Costco’s recent announcement offering Ozempic and Wegovy at $499 per month has sparked nationwide conversations among individuals seeking affordable access to GLP-1 weight loss medications. Accessibility and affordability of these popular medications have historically been a barrier for some patients, preventing them from reaping the potential weight loss benefits. Direct Meds, a leader in prescription weight loss solutions, welcomes the news while emphasizing key differences in convenience, service, and transparency that set its platform apart.

As demand for GLP-1 medications continues to surge nationwide, telehealth providers like Direct Meds are stepping in to make treatment more accessible and affordable. Direct Meds simplifies the patient experience with a fully integrated, end-to-end model, connecting patients with licensed medical providers, overseeing medication prescriptions, and delivering them directly to patients’ doors each month. Their single, all-inclusive price covers medical evaluation, online GLP-1 prescription management, medication, and shipping. It also eliminates the uncertainty and hidden fees.

“We’re glad to see more national retailers bringing visibility to GLP-1s like Ozempic and Wegovy,” said Dr. Justin Hohl, Medical Director at Direct Meds. “But the cost of the medication is only one financial hurdle patients face. At Direct Meds, we make the entire process seamless, from medical consultation to doorstep delivery, and we include the prescription in our all-in pricing. No added fees. No guesswork.”

Direct Meds also provides personalized patient support, giving individuals direct access to a care team that can help them stay on track with their weight loss journey. Every patient plan includes:

  • Online consultation with a licensed provider
  • Prescription approval and fulfillment
  • Monthly GLP-1 medication home delivery
  • Free shipping and discreet packaging
  • Ongoing access to clinical support

Direct Meds bundles everything into one predictable monthly price, often at or below national pharmacy retail rates.

“Affordability matters, but so does convenience and trust,” Hohl added. “Direct Meds was built for people who want real results without the complexity of navigating traditional healthcare systems. Costco’s move validates the demand, but we provide a simpler and more comprehensive solution.”

To learn more about the Direct Meds all-in-one model for prescription weight loss medications or to schedule a consultation with a medical provider, call (888) 696-7176 or visit www.DirectMeds.com

About Direct Meds

Direct Meds transforms how healthcare is delivered by making prescription weight loss treatments more accessible. They believe that everyone deserves effective, reliable, and medically supervised solutions to manage weight and improve overall health.

The post Direct Meds Highlights Added Value and Convenience Amid Costco’s $499 GLP-1 Offer first appeared on

Press Contact

Name: Direct Meds
Phone: 801-513-3736
Email: Contact Us

Original Press Release.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.30
+1.05 (0.46%)
AAPL  269.70
+0.70 (0.26%)
AMD  264.33
+6.32 (2.45%)
BAC  52.58
-0.29 (-0.55%)
GOOG  275.17
+6.74 (2.51%)
META  751.67
+0.23 (0.03%)
MSFT  541.55
-0.52 (-0.10%)
NVDA  207.04
+6.01 (2.99%)
ORCL  275.30
-5.53 (-1.97%)
TSLA  461.51
+0.96 (0.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.